What does the evidence say about Cacao Flavanol Exercise Performance Randomized Trial?

Updated August 2026

Quick Answer

Cacao Flavanol Exercise Performance Randomized Trial has evidence relevant to benefits, uncertainty, and practical interpretation, but conclusions should stay close to the cited sources. One representative finding is: It includes increased interferons, tumor necrosis factor, bradykinin, serine proteases, and soluble thrombomodulin, and altered clot lysis times [,,,,], all of which contribute to microvascular and thrombotic disease [,].

Key Takeaways

  • 01It includes increased interferons, tumor necrosis factor, bradykinin, serine proteases, and soluble thrombomodulin, and altered clot lysis times [,,,,], all of which contribute to microvascular and thrombotic disease [,]. [Munguía Levy (2026)]
  • 02A myriad of causes can trigger fatigue, but its development has been strongly associated with post-viral phases of infection. [Munguía Levy (2026)]
  • 03Long COVID-associated fatigue has been causally linked to sustained inflammation and to endothelial and mitochondrial dysfunction. [Munguía Levy (2026)]
  • 041 2 3 4 5 6 7 8 Coronavirus disease 2019 (COVID-19) is caused by the acute respiratory syndrome coronavirus 2 (SARS-CoV-2). [Munguía Levy (2026)]
The current Migaku evidence database contains 2 reusable source documents for Cacao Flavanol Exercise Performance Randomized Trial. This answer focuses on benefits, uncertainty, and practical interpretation. - It includes increased interferons, tumor necrosis factor, bradykinin, serine proteases, and soluble thrombomodulin, and altered clot lysis times [,,,,], all of which contribute to microvascular and thrombotic disease [,]. [Munguía Levy (2026); evidence level 2] - A myriad of causes can trigger fatigue, but its development has been strongly associated with post-viral phases of infection. [Munguía Levy (2026); evidence level 2] - Long COVID-associated fatigue has been causally linked to sustained inflammation and to endothelial and mitochondrial dysfunction. [Munguía Levy (2026); evidence level 2] - 1 2 3 4 5 6 7 8 Coronavirus disease 2019 (COVID-19) is caused by the acute respiratory syndrome coronavirus 2 (SARS-CoV-2). [Munguía Levy (2026); evidence level 2] - MetS is a multifactorial condition, with its primary indicators including obesity, hypertension, dyslipidemia, insulin resistance, and hyperglycemia; i.e., a patient who possesses at least 3 of the following parameters is designated with MetS: glucose intolerance, increased levels of triglycerides, augmented waist circumference, low levels of high-density lipoprotein cholesterol (HDL-c), and hypertension [,,]. [Tomaru Júlia Mayumi (2026); evidence level 3] Evidence levels are sorting aids, not final clinical grades. Level 1 usually indicates systematic-review style evidence, level 2 indicates randomized trials or public-health guidance, and lower levels need more cautious wording. This page is educational. People with medical conditions, pregnancy, medication use, or unusual symptoms should ask a qualified clinician before changing supplements, medication, or treatment routines.

Sources

  1. Effects of Cacao Flavonoids in Long COVID-19 Patients with Chronic Fatigue: FLALOC, a Placebo-Controlled Randomized Clinical Trial
  2. Beyond Taste: The Impact of Chocolate on Cardiovascular and Steatotic Liver Disease Risk Factors